Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 19 years of age or older
- You have been diagnosed with moderate-to-severe plaque psoriasis
- Your doctor has determined that you are a suitable candidate for light therapy or systemic (whole-body) medication
- You are about to start taking deucravacitinib as directed by the approved guidelines for this medication
Who may not be able to join:
- You are being prescribed deucravacitinib for a reason that has not been officially approved in Korea
- You have a health condition or other factor that means deucravacitinib is not considered safe for you to take, according to the official Korean prescribing guidelines set by the Ministry of Food and Drug Safety
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol-Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with adverse events (AEs); Number of participants with adverse drug reactions (ADRs); Number of participants with serious adverse events (SAEs); Number of participants with serious adverse drug reactions (SADRs); Number of participants with unexpected adverse events (AEs); Number of participants with unexpected adverse drug reactions (ADRs); Number of participants with unexpected serious adverse events (SAEs); Number of participants with unexpected serious adverse drug reactions (SADRs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.